Hello. This is Daily Stock, keeping your finger on the pulse of the Korean economy.
[Image: /stdaily/uploads/202606/gen_6a2679243288a5.34811836.png]
Key Summary
- **Record-High Export Performance**: In May 2026, South Korea's exports surged 53.2% year-on-year to $87.75 billion, marking an all-time monthly high.
- **Unprecedented Trade Surplus**: The trade balance in May recorded a surplus of $26.95 billion, bringing the cumulative surplus for Jan-May to $101.91 billion. This surpassed the previous annual record surplus of 2017 ($95.2 billion) in just five months.
- **K-Consumer Goods Leader, Cosmetics**: Cosmetics exports in May reached $1.18 billion, shattering previous records for any month of May and surpassing K-food to become the number one export product among the five major consumer goods categories.
- **The Rise of ODM Giants**: Driven by explosive beauty export growth, leading Original Development Manufacturing (ODM) companies such as Kolmar Korea (161890) and Cosmax (192820) are accelerating proactive investments, including factory expansions and supply chain digitization.
Market Context
As of the market close on June 8, 2026, the USD/KRW exchange rate remained elevated at 1,531.50 won, providing a favorable environment for exporters to boost their KRW-denominated financial results.
However, the KOSPI index faced correction pressure, closing at 7,484.41, indicating that overall market sentiment remains cautious at the Fear (21.6) stage according to our proprietary Fear & Greed Index.
Despite this supply-demand volatility, investment is shifting heavily toward export stocks backed by strong fundamental performance.
In particular, while semiconductors continue to dominate (accounting for 42.3% of total exports), the cosmetics sector has shown a remarkable structural turnaround, cementing its position as a top-tier consumer goods export.
Exports to the US rose 40.5% year-on-year, while European markets (including the UK and Netherlands) registered triple-digit growth rates, representing a successful market diversification away from past over-reliance on China.
[Image: /stdaily/uploads/202606/gen_6a267930919ea5.11018989.png]
Financial Analysis
Kolmar Korea and Cosmax, the primary beneficiaries of the K-Beauty boom, demonstrated robust growth visibility in their Q1 2026 earnings.
Kolmar Korea recorded consolidated revenue of 728 billion won and an operating profit of 78.9 billion won in Q1 2026, representing an "earnings surprise" that beat market consensus (66.2 billion won) by approximately 19%.
Its domestic subsidiary's separate operating profit skyrocketed 51.2% to 51.2 billion won, driven by operating leverage from the rapid growth of its largest sunscreen clients and the official commencement of orders from global multinational corporation (MNC) luxury brands.
Cosmax recorded Q1 consolidated revenue of 682 billion won and an operating profit of 53 billion won, slightly missing market consensus by 4% on operating profit, though its top-line grew 15.9% year-on-year.
Although margins temporarily flattened due to a minor shift in the product mix (with low-margin products rising and high-margin color cosmetics temporarily declining), the underlying foundation for growth remains solid. This is supported by surging orders from local indie brands for its US subsidiary and strong expectations for turning a profit (BEP) in Q2.
| Company (Ticker) | Q1 2026 Revenue (Consolidated) | YoY Change | Q1 2026 Operating Profit (Consolidated) | YoY Change | Highlights |
|---|---|---|---|---|---|
| **Kolmar Korea** (161890) | KRW 728.0B | +11.5% | KRW 78.9B | +31.6% | Beat consensus by 19%, surge in sun care & MNC orders |
| **Cosmax** (192820) | KRW 682.0B | +15.9% | KRW 53.0B | +10.9% | Robust US orders, targeting Q2 BEP turnaround |
Valuation
Kolmar Korea's current stock price trades at a 12-month forward P/E (Price-to-Earnings) ratio of around 10 to 14 times, making it relatively undervalued compared to its global ODM peers.
With domestic growth visibility improving, there is room for upward adjustments to future earnings per share (EPS) estimates.
Cosmax recently underwent a price correction due to concerns over a temporary delay in product mix improvements. However, it is returning to a stable double-digit growth path alongside a 3% to 6% upgrade in its 12-month forward EPS estimates.
Discussions are ongoing regarding a potential mid-to-long-term valuation re-rating, fueled by narrowing losses in its US business and its full-scale entry into Europe following the acquisition of Italian ODM firm Keminova.
Expert & Institutional Perspectives
Securities analysts evaluate the rapid growth of K-Beauty, as indicated by May's export data, not as a short-term fad but as a structural shift driven by supply chain reorganizations.
This trend is accelerating as major global beauty corporations reduce in-house manufacturing to partner with Korea's advanced ODM platforms to counter fast-moving indie brands.
Institutional capital is gradually flowing into large-scale ODM players positioned to benefit from the high USD/KRW exchange rate in the 1,530 won range.
DB Financial Investment maintained its 'Buy' rating and target price of 130,000 won for Kolmar Korea, positively evaluating its global customer diversification. Meanwhile, Hanwha Investment & Securities raised its target price for Cosmax to 250,000 won, highlighting the speed of its operational restructuring.
Risks to Watch
- **Raw Material & Logistics Cost Pressures**: Continued geopolitical risks and high oil prices could increase naphtha prices (used for packaging procurement) and ocean freight rates, putting pressure on profit margins.
- **Delayed Overseas Factory Normalization**: If the stabilization of Kolmar Korea's second US factory or Cosmax's US turnaround takes longer than expected, it could act as a drag on consolidated global earnings.
- **Exchange Rate Volatility**: While the current high rate of 1,531.50 won benefits exporters, any sudden drop in the exchange rate due to shifting global macroeconomic conditions presents a short-term margin contraction risk.
Investment Outlook
Record-high May exports and a historic trade surplus provide strong fundamental support for the KOSPI index to weather the current market fear (Fear & Greed Index at 21.6).
At the forefront of this recovery, the K-Beauty sector continues its high-quality growth, backed by expanding market share in North America and Europe.
Kolmar Korea's proprietary sun care formulations and growing multinational contract wins, alongside Cosmax's global channel rebalancing and European expansion, present highly attractive fundamental metrics.
For strategic investors, temporary cost increases and market sentiment adjustments could represent attractive entry points for accumulation.
[Image: /stdaily/uploads/202606/gen_6a26793d57b932.92018419.png]
Investor FAQ
Q1. What drove South Korea's record-breaking export performance in May?
A1. A surge in demand for semiconductors (HBM, SSD, etc.) fueled by big tech AI data center investments, combined with record-setting cosmetics exports driven by growing global preference for K-Beauty.
Q2. Why should investors focus on ODM companies within the cosmetics sector?
A2. As global beauty trends diversify away from a few conglomerates toward a wide range of indie brands, Korea's high-performance ODM ecosystem serves as an indispensable manufacturing hub for these new brands.
Q3. How does the high exchange rate of 1,531.50 won affect cosmetics exporters?
A3. Direct exports, which are mostly settled in US dollars, see direct benefits in translated KRW revenues and operating profits, creating a positive exchange rate effect.
Q4. Are recent concerns regarding raw material supply chains (such as naphtha) significant?
A4. While the direct impact on active cosmetic ingredients is minimal, it could raise plastic-based packaging costs. Companies are mitigating this by diversifying their supply chains and shifting to recycled materials.
Q5. Why is a turnaround in US subsidiaries so critical?
A5. Historically, losses from overseas subsidiaries have weighed on overall consolidated earnings. Achieving profitability through improved capacity utilization is expected to be a primary trigger for valuation re-rating.